About Vascutek
Vascutek is a Healthcare company based in Inchinnan (United Kingdom) founded in 1982, and was acquired by Terumo Medical in June 2002. It operates as a products for vascular and cardiovascular markets are developed. The company has 800 employees. Vascutek has completed 1 acquisition, including Serom Medical Technology. Vascutek offers products and services including Relay®Pro, TREO®, Anaconda™, Thoraflex™ Hybrid, and Gelweave™. Its focus areas include Life Sciences, Cardiac and Vascular Disorders, Medical Devices and Therapeutic Devices. Its legal entity is VASCUTEK LIMITED. Its competitors include Cardiovascular Systems, Contego Medical, AngioScore, Echopoint Medical and Shape Memory Medical and 5 more; 9 of its 10 listed competitors have raised funding.
Company details
Vascutek was founded in 1982 in Inchinnan, United Kingdom, and focuses on the vascular and cardiovascular sector. Products are designed and developed, including polyester vascular grafts, fluoropolymer cardiovascular patches, aortic root grafts, repair patches, and ePTFE grafts for applications in vascular access, peripheral, abdominal, thoracoabdominal, cardiothoracic, cardiac, and endovascular procedures. The company was acquired by Terumo in October 2012 for 172 million.
- Headquarters Inchinnan, United Kingdom
- Employees 800
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Website vascutek.com
- Social LinkedIn X Facebook
- Acquired by Terumo Medical (Jun 2002)
- Legal Name Vascutek Limited
- Date of Incorporation 16 Aug, 1982
- Jurisdiction RENFREWSHIRE
- Annual Revenue$115.27 M (USD)-2as on Mar 31, 2021
- Net Profit$14.89 M (USD)12as on Mar 31, 2021
- Investors
- Employee Count800
- Investments & Acquisitions
- Acquired byTerumo Medical
(Jun 2002)
Products & Services of Vascutek
Vascutek offers a comprehensive portfolio of products and services, including Relay®Pro, TREO®, Anaconda™, Thoraflex™ Hybrid, and Gelweave™.
Stent-graft for aortic repair and disease management.
System for endovascular aneurysm repair and sac regression.
Flexible stent for aortic treatment and vascular solutions.
Platform for surgical and endovascular aortic interventions.
Graft for vascular repair and disease treatment options.
Investors in Vascutek
Vascutek has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Terumo Medical.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Portfolio of medical devices for interventional cardiology is provided. | 1921 | terumo.com | Somerset, United States |
Investor details for Vascutek
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Vascutek
Vascutek has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Serom Medical Technology.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Surgical devices are manufactured for multiple therapeutic areas. | serom.com | Roma, Italy | 1996 | Oct 2018 | •••• |
Complete acquisition details for Vascutek
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Vascutek
3 dated milestones of Vascutek across 36 years, from founding to its latest funding, stage changes and deals.
- Founded Vascutek is founded.
- Exit Acquired by Terumo Medical.
- Acquisition Acquires Serom Medical Technology.
Competitors of Vascutek
Vascutek has 10 listed competitors in our database, 9 of them funded. They include Cardiovascular Systems, Contego Medical, AngioScore, Echopoint Medical and Shape Memory Medical, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| csi360.com | 1989 | Saint Paul, United States | $121.2M | 780 | Devices for treating peripheral and coronary vascular disease are developed. | |
| contegomedical.com | 2005 | Raleigh, United States | $66.01M | – | Provider of vascular stenting with embolic protection for both coronary and peripheral vasculature | |
| angioscore.com | 2003 | Fremont, United States | $87M | – | Scoring balloon catheters for coronary and peripheral angioplasty are developed. | |
| echopointmedical.com | 2018 | London, United Kingdom | $9.74M | 8 | Smart devices for monitoring coronary artery disease are developed. | |
| shapemem.com | 2009 | Santa Clara, United States | $77.27M | 37 | Embolization devices are developed using Shape Memory Polymer foams. | |
| limflow.com | 2012 | Paris, France | $97.45M | – | Developer a system for venous arterialization of the lower limbs | |
| terumo.com | 1921 | Somerset, United States | – | – | Portfolio of medical devices for interventional cardiology is provided. | |
| vasc.com | 1997 | Minneapolis, United States | $12M | 562 | Products for vascular diagnostics and interventional procedures are developed. | |
| ev3.net | 2000 | Plymouth, United States | $58.8M | 1,307 | Surgical products for treatment of Peripheral vascular & Neurovascular diseases | |
| relisysmedicaldevices.org | 1997 | Ranga Reddy, India | $23.63M | 250 | Medical devices for cardiovascular and structural heart treatments are supplied. |
Detailed competitors of Vascutek
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Vascutek
Websites that share an audience with Vascutek (vascutek.com).
Websites whose visitors overlap most with Vascutek. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| terumo-cvs.com | 100% | – | – | View details | |
 fistula.wordpress.com | fistula.wordpress.com | 89% | – | – | – |
| microvention.com | 87% | – | – | View details | |
| cookmedical.com | 87% | – | #429,169 | View details | |
| abbottvascular.com | 87% | – | – | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 17 similar websites and full traffic analytics for Vascutek
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 17 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Cardiac and Vascular Disorders
10 companies that operate in the same segment as Vascutek (Cardiac and Vascular Disorders), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Connected devices for health, sleep, and activity monitoring are developed. | 2008 | Moulineaux, Seine-maritime, France | USD 93.83 M | – | – | |
SMT is recognized as a developer of cardiovascular medical devices. | 1998 | Surat, Gujarat, India | – | USD 106.25 M | 1,090 | |
Gene-editing therapies for coronary artery disease are developed. | 2018 | Cambridge, Massachusetts, United States | USD 215.5 M | – | 255 | |
Cardiac monitoring devices and applications are provided for heart health. | 2010 | Mountain View, California, United States | USD 114.38 M | USD 6.18 M | 67 | |
Therapies for lowering low-density lipoprotein cholesterol levels are developed. | 1998 | Ann Arbor, Michigan, United States | USD 129.7 M | USD 332.31 M | 304 | |
Cloud-based ambulatory ECG monitors for cardiac arrhythmia diagnosis are provided. | 2006 | San Francisco, California, United States | USD 109.23 M | USD 747.14 M | 2,000 | |
Provider of neuroprotection devices for carotid artery disease | 2007 | Sunnyvale, California, United States | USD 241.8 M | – | – | |
Miniaturized wireless implantable sensors are developed for hemodynamic monitoring. | 2007 | East Peoria, Illinois, United States | USD 154.77 M | – | 104 | |
Access catheters for neurovascular stroke treatment are provided. | 2015 | Campbell, California, United States | USD 596 M | – | – | |
Biosensor patches are developed for monitoring multiple body vitals. | 2011 | Campbell, California, United States | USD 239.95 M | – | 184 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Vascutek
Vascutek was founded in 1982.
Vascutek is headquartered in Inchinnan, United Kingdom. It is registered at Inchinnan, Renfrewshire, United Kingdom.
Vascutek has 800 employees.
Annual revenue of Vascutek is $115.27M as on Mar 31, 2021.
Vascutek was founded in 1982 in Inchinnan, United Kingdom, and focuses on the vascular and cardiovascular sector. Products are designed and developed, including polyester vascular grafts, fluoropolymer cardiovascular patches, aortic root grafts, repair patches, and ePTFE grafts for applications in vascular access, peripheral, abdominal, thoracoabdominal, cardiothoracic, cardiac, and endovascular procedures. The company was acquired by Terumo in October 2012 for 172 million.
Vascutek's top competitors include Contego Medical, Limflow and Shape Memory Medical.
Vascutek offers Relay®Pro, TREO®, Anaconda™, Thoraflex™ Hybrid, and Gelweave™.
Vascutek has made 1 acquisition, including Serom Medical Technology.
Vascutek has 1 investor. Key investors include Terumo Medical.
Vascutek operates through Vascutek Limited.
Yes. Vascutek was acquired by Terumo Medical in June 2002.